However, the expression of VEGF was demonstrated in the dermis (fibroblasts), dermal, and subcutaneous white adipose tissue by 500 μg/cm2 SCC treatment while TSC application (500 μg/cm2) showed elevated VEGF expression in the epidermis (keratinocytes) on day 5. Here, VEGFA is linked to tuberous sclerosis.